Joseph K. Belanoff
Chief Executive Officer at Corcept Therapeutics Incorporated
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Corcept Therapeutics Incorporated, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Corcept Therapeutics Incorporated May 21, 202699.6%
-
Corcept Therapeutics Incorporated June 10, 202599.8%
-
Corcept Therapeutics Incorporated May 17, 202499.6%
-
Corcept Therapeutics Incorporated May 19, 202399.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Corcept Therapeutics Incorporated | Open-market sale | −12,837 | $69.74 | $895,252 |
| May 29, 2026 | Corcept Therapeutics Incorporated | Gift | −300,000 | — | — |
| May 29, 2026 | Corcept Therapeutics Incorporated | Gift | +150,000 | — | — |
| May 29, 2026 | Corcept Therapeutics Incorporated | Gift | +150,000 | — | — |
| May 1, 2026 | Corcept Therapeutics Incorporated | Open-market sale | −40,000 | $50.10 | $2,004,000 |
| Mar 25, 2026 | Corcept Therapeutics Incorporated | Open-market sale | −26,198 | $50.07 | $1,311,734 |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Option exercise | +550,000 | $3.88 | $2,134,000 |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Shares withheld for tax | −306,846 | $83.59 | $25,649,257 |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Gift | −243,154 | — | — |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Other | +243,154 | — | — |
| Dec 1, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −40,000 | $79.77 | $3,190,800 |
| Nov 5, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −14,355 | $74.20 | $1,065,141 |
| Nov 5, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −10,837 | $75.14 | $814,292 |
| Nov 5, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −3,590 | $75.98 | $272,768 |
| Nov 3, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −11,218 | $74.08 | $831,029 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.